Metabolomic analysis of livers and serum from high-fat diet induced obese mice

Journal of Proteome Research

Volumn 10, Issue 2, 2011, Pages 722-731

  Kim, Hyun Jin ^a   Kim, Jin Hee ^a   Noh, Siwon ^a   Hur, Haeng Jeon ^a   Sung, Mi Jeong ^a   Hwang, Jin Taek ^a   Park, Jae Ho ^a   Yang, Hye Jeong ^a   Kim, Myung Sunny ^a   Kwon, Dae Young ^a   Yoon, Suk Hoo ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

oxidation; Acylcarnitine; Betaine; Carnitine; GC MS; High fat diet; Lysophosphatidylcholine; Metabolomics; Obesity; Serotonin; UPLC Q TOF

Indexed keywords

ACETANILIDE; ACYLCARNITINE; ARGININE; BENZOIC ACID; BETAINE; CARNITINE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCEROL; LINOLEIC ACID; LYSOPHOSPHATIDYLCHOLINE; MALTOSE; MELIBIOSE; MONOSACCHARIDE; OLEIC ACID; PALMITIC ACID; PANTOTHENIC ACID; PHENYLPYRUVIC ACID; PHOSPHATIDYLCHOLINE; PIPECOLIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SEROTONIN; STEARIC ACID; TRIACYLGLYCEROL; TYROSINE; URIC ACID; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIVER METABOLISM; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; SERUM; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY FATS; DISCRIMINANT ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEP G2 CELLS; HISTOCYTOCHEMISTRY; HUMANS; LEAST-SQUARES ANALYSIS; LIPID METABOLISM; LIVER; LYSOPHOSPHATIDYLCHOLINES; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MICE; MICE, INBRED C57BL; MICE, OBESE; MULTIVARIATE ANALYSIS; OBESITY;

MUS;

EID: 79955433960     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100892r     Document Type: Article

References (42)

1. Buschemeyer, W. C., III; Freedland, S. J. Obesity and prostate cancer: epidemiology and clinical implications. Eur. Urol. 2007, 52, 331-343. (Pubitemid 46963472)
2. Ogden, C. L.; Carroll, M. D.; Curtin, L. R.; McDowell, M. A.; Tabak, C. J.; Flegal, K. M. Prevalence of overweight and obesity in the United States, 1999-2004. J. Am. Med. Assoc. 2006, 295, 1549-1555.
3. Popkin, B. M.; Kim, S.; Rusev, E. R.; Du, S.; Zizza, C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes. Rev. 2006, 7, 271-293. (Pubitemid 44086904)
4. Conway, B.; Rene, A. Obesity as a disease: no lightweight matter. Obes. Rev. 2004, 5, 145-151. (Pubitemid 38998239)
5. Kahn, B. B.; Alquier, T.; Carling, D.; Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1, 15-25. (Pubitemid 43960587)
6. Moon, H.-S.; Lee, H.-G.; Choi, Y.-J.; Kim, T.-G.; Cho, C.-S. Proposed mechanism of (-)-epigallocatechin-3-gallate for anti-obesity. Chemico-Biol. Inter. 2007, 167, 85-98.
7. Madsen, L.; Petersen, R. K.; Kristiansen, K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim. Biophys. Acta 2005, 1740, 266-686.
8. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabolomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29 (11), 1181-1189.
9. Kim, S. H.; Yang, S. O.; Kim, H. S.; Kim, Y.; Park, T.; Choi, H. K. 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal. Bioanal. Chem. 2009, 395 (4), 1117-1124.
10. Shearer, J.; Duggan, G.; Weljie, A.; Hittel, D. S.; Wasserman, D. H.; Vogel, H. J. Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes Obes. Metab. 2008, 10 (10), 950-958.
11. Serkova, N. J.; Jackman, M.; Brown, J. L.; Liu, T.; Hirose, R.; Roberts, J. P.; Maher, J. J.; Niemann, C. U. Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol. 2006, 44 (5), 956-962.
12. Loftus, N.; Miseki, K.; Iida, J.; Gika, H. G.; Theodoridis, G.; Wilson, I. D. Profiling and biomarker identification in plasma from different Zucker rat strains via high mass accuracy multistage mass spectrometric analysis using liquid chromatography/mass spectrometry with a quadrupole ion trap-time of flight mass spectrometer. Rapid Commun. Mass Spectrom. 2008, 22, 2547-2554.
13. Kim, J. Y.; Park, J. Y.; Kim, O. Y.; Ham, B. M.; Kim, H.-J.; Kwon, D. Y.; Jang, Y.; Lee, J. H. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J. Proteome Res. 2010, 9 (9), 4368-4375.
14. Shirouchi, B.; Nagao, K.; Inoue, N.; Ohkubo, T.; Hibino, H.; Yanagita, T. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J. Agric. Food Chem. 2007, 55 (17), 7170-7176. (Pubitemid 47338962)
15. Rittes, P. G. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast. Surg. 2003, 27 (4), 315-318. (Pubitemid 38076368)
16. Noga, A. A.; Vance, D. E. Insights into the requirement of phosphatidylcholine synthesis for liver function in mice. J. Lipid Res. 2003, 44 (10), 1998-2005. (Pubitemid 37356673)
17. Galili, O.; Versari, D.; Sattler, K. J.; Olson, M. L.; Mannheim, D.; McConnell, J. P.; Chade, A. R.; Lerman, L. O.; Lerman, A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2007, 292 (2), H904-H911.
18. Pietiläinen, K. H.; Sysi-Aho, M.; Rissanen, A.; Seppänen- Laakso, T.; Yki-Järvinen, H.; Kaprio, J.; Oresic, M. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS ONE 2007, 2 (2), e218.
19. Aiyar, N.; Disa, J.; Ao, Z.; Ju, H.; Nerurkar, S.; Willette, R. N.; Macphee, C. H.; Johns, D. G.; Douglas, S. A. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol. Cell. Biochem. 2007, 295 (1-2), 113-120. (Pubitemid 46157993)
20. Schmitz, G.; Ruebsaamen, K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010, 208 (1), 10-18.
21. Lopez-Garcia, E.; Schulze, M. B.; Meigs, J. B.; Manson, J. E.; Rifai, N.; Stampfer, M. J.; Willett, W. C.; Hu, F. B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135 (3), 562-566. (Pubitemid 40365218)
22. Lin, S. J.; Guarente, L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr. Opin. Cell Biol. 2003, 15 (2), 241-246. (Pubitemid 36332200)
23. Um, J. H.; Park, S. J.; Kang, H.; Yang, S.; Foretz, M.; McBurney, M. W.; Kim, M. K.; Viollet, B.; Chung, J. H. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59 (3), 554-563.
24. Lever, M.; Slow, S. The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin. Biochem. 2010, 43 (9), 732-744.
25. Steiber, A.; Kerner, J.; Hoppel, C. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol. Aspects Med. 2004, 25 (5-6), 455-473. (Pubitemid 39195071)
26. Osei-Hyiaman, D.; Liu, J.; Zhou, L.; Godlewski, G.; Harvey-White, J.; Jeong, W. I.; Bátkai, S.; Marsicano, G.; Lutz, B.; Buettner, C.; Kunos, G. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J. Clin. Invest. 2008, 118 (9), 3160-3169.
27. Ronnett, G. V.; Kim, E. K.; Landree, L. E.; Tu, Y. Fatty acid metabolism as a target for obesity treatment. Physiol. Behav. 2005, 85 (1), 25-35. (Pubitemid 40744974)
28. Priego, T.; Sáenchez, J.; Palou, A.; Picó, C. Effect of high-fat diet feeding on leptin receptor expression in white adipose tissue in rats: depot-and sex-related differential response. Genes Nutr. 2009, 4 (2), 151-156.
29. Reddy, B. S.; Engle, A.; Simi, B.; O'Brien, L. T.; Barnard, R. J.; Pritikin, N.; Wynder, E. L. Effect of low-fat, high-carbohydrate, high-fiber diet on fecal bile acids and neutral sterols. Prev. Med. 1988, 17 (4), 432-439.
30. Leibowitz, S. F.; Alexander, J. T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 1998, 44 (9), 851-864. (Pubitemid 28520223)
31. Tecott, L. H.; Sun, L. M.; Akana, S. F.; Strack, A. M.; Lowenstein, D. H.; Dallman, M. F.; Julius, D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374 (6522), 542-546.
32. Berger, M.; Gray, J. A.; Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 2009, 60, 355-66.
33. Garfield, A. S.; Heisler, L. K. Pharmacological targeting of the serotonergic system for the treatment of obesity. J. Physiol. 2009, 587, 49-60.
34. Shimizu, H.; Fisler, S.; Bray, G. A. Extracellular hypothalamic monoamines measured by in vivo microdialysis in a rat model of dietary fat-induced obesity. Obes. Res. 1994, 2 (2), 100-109.
35. Ghia, J.-E.; Li, N.; Wang, H.; Collins, M.; Deng, Y.; El-Sharkawy, R. T.; Côté, F.; Mallet, J.; Khan, W. I. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 2009, 137, 1649-1660.
36. Fardet, A.; Llorach, R.; Martin, J. F.; Besson, C.; Lyan, B.; Pujos-Guillot, E.; Scalbert, A. A liquid chromatography-quadrupole timeof-flight (LC-QTOF)-based metabolomic approach reveals new metabolic effects of catechin in rats fed high-fat diets. J. Proteome Res. 2008, 7 (6), 2388-2398.
37. Gagliardi, A. C.; Miname, M. H.; Santos, R. D. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009, 202 (1), 11-17.
38. Cirillo, P.; Sato, W.; Reungui, S.; Heinig, M.; Gersch, M.; Sautin, Y.; Nakagawa, T.; Johnson, R. J. Uric acid, the metabolic syndrome, and renal disease. J. Am. Soc. Nephrol. 2006, 17 (12 Suppl 3), S165-S168. (Pubitemid 44865243)
39. Iseki, K.; Oshiro, S.; Tozawa, M.; Iseki, C.; Ikemiya, Y.; Takishita, S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens. Res. 2001, 24 (6), 691-697. (Pubitemid 33133783)
40. Segura, J.; Campo, C.; Ruilope, L. M. How relevant and frequent is the presence of mild renal insufficiency in essential hypertension. J. Clin. Hypertens. (Greenwich) 2002, 4 (5), 332-336. (Pubitemid 35214725)
41. Tseng, C. H. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int. 2005, 68 (2), 796-801.
42. Newgard, C. B.; An, J.; Bain, J. R.; Muehlbauer, M. J.; Stevens, R. D.; Lien, L. F.; Haqq, A. M.; Shah, S. H.; Arlotto, M.; Slentz, C. A.; Rochon, J.; Gallup, D.; Ilkayeva, O.; Wenner, B. R.; Yancy, W. S., Jr.; Eisenson, H.; Musante, G.; Surwit, R. S.; Millington, D. S.; Butler, M. D.; Svetkey, L. P. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9 (4), 311-326.